For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Sanofi Pasteur Biologics, LLC

USPTO Granted Patents = 24

CIPO Patents = 26

EPO Patents = 19

Trademarks = 1

Forward Citations = 32

Loading Chart...

Loading Chart...

62 inventors (with patents filed for the assignee):

Simon Delagrave (10 out of 13 patents)

Harold Kleanthous (8 out of 16 patents)

Farshad Guirakhoo (7 out of 16 patents)

4. Stephen F Anderson (6 out of 8 patents)

5. Konstantin V Pugachev (6 out of 10 patents)

6. Thomas P Monath (5 out of 33 patents)

7. Sophia Mundle (4 out of 5 patents)

8. Alexander A Rumyantsev (4 out of 4 patents)

9. John Hamberger (3 out of 4 patents)

10. Peter Ciarametaro (3 out of 5 patents)

11. Natalie Anosova (2 out of 3 patents)

12. Nicola Beltraminelli (2 out of 6 patents)

13. Pierre Garrone (2 out of 11 patents)

14. Jianxin Zhang (2 out of 5 patents)

15. Majid Mehtali (2 out of 3 patents)

24 patents: Sort by Forward Citations

1. 11260123 - Herpesvirus compositions and related methods (2022-03-01),

2. 11224650 - Purification of herpes virus (2022-01-18),

3. 11220537 - Antibodies againsttoxins and methods of using the same (2022-01-11),

4. 10639362 - Pharmaceutical compositions containingtoxoids A and B (2020-05-05),

5. RE47768 - Compositions and methods for the production of alpha-herpesviruses (2019-12-16),

6. 10363304 - Purification of herpes virus (2019-07-30),

7. 10208292 - ICP0-mediated enhanced expression system (2019-02-19),

8. 10172929 - Flavivirus vaccines (2019-01-08),

9. 10160797 - [object Object] (2018-12-25),

10. 9381237 - Neutralizing immunogen (NimIV) of rhinovirus and its uses for vaccine applications (2016-07-05),

11. 9365832 - Purification of herpes virus (2016-06-14),

12. 9320790 - [object Object] (2016-04-26),

13. 9228203 - Recombinant bicistronic flavivirus vectors (2016-01-05),

14. 9226956 - [object Object] (2016-01-05),

15. 9217158 - Replication-defective flavivirus vaccines and vaccine vectors (2015-12-22),

Sanofi Pasteur Biologics, LLC is a leading global biopharmaceutical company that focuses on the prevention and treatment of infectious diseases. They are dedicated to providing innovative vaccines to protect people's health. With a rich history in vaccine development and manufacturing, Sanofi Pasteur Biologics strives to make a difference in the lives of individuals and communities worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

24 Patents

#95 in Cambridge, MA

#800 in Massachusetts

#13,392 in US

#25,806 in the World

Cambridge, MA, United States of America

Sanofi Pasteur Biologics, LLC

Forward Citations = 32

62 inventors:

Simon Delagrave (10 out of 13 patents)

Harold Kleanthous (8 out of 16 patents)

Farshad Guirakhoo (7 out of 16 patents)

4. Stephen F Anderson (6 out of 8 patents)

5. Konstantin V Pugachev (6 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…